Tony G Co-Investment Holdings Ltd (TSE:TONY) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tony G Co-Investment Holdings Ltd. announces significant progress for Alclin, a company in its investment portfolio, as it secures overseas site registration and a drug registration for its NAD+ product. Alclin has also increased its production capacity significantly and received a license from South Africa’s regulatory authority to manufacture, import, and export its growing product range. This marks a key development in their strategy focused on longevity products.
For further insights into TSE:TONY stock, check out TipRanks’ Stock Analysis page.